Article
Treatment of breast cancer 2 (BRCA2)-mutant follicular dendritic cell sarcoma with a poly ADP-ribose polymerase (PARP) inhibitor: a case report.
BMC research notes - 3 Aug 2016
Lemech Charlotte R, Williams Rachel, Thompson Stephen R, McCaughan Brian, Chin Melvin
Abstract excerpt
BACKGROUND: Follicular dendritic cell sarcoma is a rare tumour with clinical behaviour covering a spectrum from indolent to aggressive disease. Treatment recommendations are currently based on case reports and small series describing combinations of surgery, chemotherapy and radiotherapy providing the best patient outcomes. Recent knowledge on molecular aberrations in this disease have not yet impacted on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
